名优中药品种二次开发临床定位的关键问题  

Key Points for Clinical Orientation in the Secondary Development of Famous and Superior Chinese Patent Drugs

作　　者：商洪才[1,2] 刘洋[1] 张俊华[1] 王辉[1] 徐宏娟[1] 张伯礼[1] 李幼平[2] 

机构地区：[1]天津中医药大学,天津300193 [2]四川大学华西医院

出　　处：《中国中西医结合杂志》2008年第10期939-940,共2页Chinese Journal of Integrated Traditional and Western Medicine

基　　金：国家自然科学基金项目(No.30600834);中国博士后科学基金项目(No.20070411156);天津市科技创新专项资金项目(No.07FD2DSH01011)

摘　　要：针对名优中药二次开发过程中普遍存在的问题,提出临床定位的概念,阐明了临床定位在名优中药品种二次开发中的必要性,探索建立了名优中药品种临床定位的确定方法,指出了明确临床定位的关键所在,为名优中成药二次开发的顺利实施奠定了理论基础。Aimed at the ubiquitous problems in the secondary development of famous and superior Chinese patent drugs, the concept of clinical orientation is suggested by the authors. Its necessity in secondary development was explained and the method for establishment and confirmation was explored in this paper, which set up a favorable basis for secondary development of famous and superior Chinese patent drugs.

关 键 词：名优中药 二次开发 临床定位 

分 类 号：R28[医药卫生—中药学]